After stomach cancer is diagnosed, a team of cancer specialists will work together with you to develop a personalized ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Within hours of getting inked, pigments begin migrating through your body, building up in immune tissues and triggering ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Tattoos have gained widespread popularity, with nearly one in three Americans having at least one. But beneath the colorful designs lurks a hidden journey. According to a new study, tattoo ink doesn’t ...

Chronic lymphocytic leukemia (CLL) is a type of cancer affecting a type of white blood cell in the blood and bone marrow. It often progresses slowly and is diagnosed most often during routine blood ...

Mouse research shows tattoo pigments move into lymph nodes within minutes and persist for months Ink triggered immune-cell death, chronic inflammation and weakened response to an mRNA COVID shot ...

A 64-year-old man undergoing treatment for colon adenocarcinoma underwent imaging tests n for metastasis screening. A chest CT scan revealed a small, triangular nodule in the left lung, closely ...

ABSTRACT: Background: Metastasis to the lymph nodes is the most prognostic factor in patients with oral cancer. The antegrade lymphatic flow in patients with normal anatomy and physiology makes ...

Justin Stebbing does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Introduction: The prognostic value of determining mRNA levels of two markers for regulatory T cells, IL-10 and FoxP3, in lymph nodes (LNs) and primary tumors of colon cancer (CC) patients receiving ...